Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012

Cited by (307)

Items 201–300 of 307

1. Place of durvalumab in the treatment of biliary tract cancer: A review
   Valeriy Vladimirovich Breder, Evgenii V. Ledin, Viacheslav A Chubenko, Рашида Вахидовна Орлова, Владислав Владимирович Петкау, Илья Анатольевич Покатаев · 2023 · Journal of Modern Oncology
2. COTE1 Facilitates Intrahepatic Cholangiocarcinoma Progression via Beclin1‐Dependent Autophagy Inhibition
   Hai Zhang, Shu Chen, Sanrong Xu, Xiangcheng Li · 2023 · BioMed Research International
3. Impact of socio‐economic environment on incidence of primary liver cancer in France between 2006 and 2016
   Bertille Comoz, Isabelle Ollivier‐Hourmand, Anne‐Marie Bouvier, Jean‐Baptiste Nousbaum, Thi Thu Nga Nguyen, Guy D. Launoy, Véronique Bouvier, Joséphine Bryère · 2023 · Liver International
4. Second-line FOLFOX is not the standard of care for all patients with advanced biliary tract cancer—a commentary from the Young International Society of Geriatric Oncology
   Gabor Istvan Liposits, Sankalp Arora, Nicolò Matteo Luca Battisti, Enrique Soto‐Pérez‐de‐Celis, K.P. Loh, Grant Richard Williams · 2023 · Annals of Oncology
5. Impact of clinical lymph node status on survival in patients with intrahepatic cholangiocarcinoma undergoing liver resection plus lymphadenectomy
   Hongling Wang, Xingwu Zhu, Maixuan Qiu, Jianbing Xuan, Xiaodong Shi, Liang Huang, Kui Wang, Jing Li · 2024 · ANZ Journal of Surgery
6. Bile level of cytokeratin 7 as a diagnostic marker for cholangiocarcinoma: a case-control study in Egyptian patients
   Ali Nada, Alzhraa Alkhatib, Fady Abdelmalik, Mona Gamal El-Abd, Naglaa Said Elabd, Hossam El-Din Abdel-Latif · 2024 · Egyptian Liver Journal
7. Hepatic adenosquamous carcinoma with sarcomatous transformation: a case report and review of the literature
   Quynh Thi Nguyen, Hiep Canh Nguyen, Kenta Takahashi, Kaori Yoshimura, Hiroko Ikeda, Kazuto Kozaka, Zihan Li, Dong Thanh Le, Rui Yang, Shintaro Yagi et al. · 2024 · Medical Molecular Morphology
8. Viral Hepatitis in Western Patients with Advanced Intrahepatic Cholangiocarcinoma: Retrospective Assessment of Prevalence, Prognostic and Predictive Significance
   Roberto Filippi, Giovanni Brandi, Andrea Casadei Gardini, Francesco Leone, Nicola Silvestris, Maria Antonietta Satolli, Francesca Salani, Elisa Sperti, Stefania Eufemia Lutrino, Giuseppe Aprile et al. · 2024 · Cancer Investigation
9. Mass‐forming intrahepatic cholangiocarcinoma: treatment outcomes after curative‐intent resection in an Australian tertiary referral hospital
   Sander R. W. J. Martens, Nazim Bhimani, Cameron Gofton, Kai M. Brown, Philip R. de Reuver, Thomas J. Hugh · 2024 · ANZ Journal of Surgery
10. The genome sequence of the liver fluke Opisthorchis viverrini (Poirier, 1886) Stiles & Hassall, 1896
    Arporn Wangwiwatsin, Siriyakorn Kulwong, Chitsakul Phuyao, Attapol Titapun, Watcharin Loilome, Poramate Klanrit, Nisana Namwat, Paiboon Sithithaworn, Stephen R. Doyle, Matthew Berriman et al. · 2025 · Wellcome Open Research
11. Primary Cholangiocarcinoma of the Liver Presenting as a Complicated Hepatic Cyst: A Diagnostic Challenge
    Chang Won Ha, Sang Deok Shin, Myung Ji Goh, Byeong Geun Song, Wonseok Kang, Dong Hyun Sinn, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee · 2025 · Korean Journal of Gastroenterology
12. Cholangiocarcinoma in Denmark: Time-trends in incidence and mortality
    Morten Daniel Jensen, Joe West, Britta Weber, Frank Viborg Mortensen, Peter Jepsen · 2025 · JHEP Reports
13. Burden and trajectories of biliary tract malignancies in Taiwan from 1998 to 2022
    Chung‐Hsin Tsai, Й. Х. Чиен, Shih‐Ping Cheng · 2025 · International Journal of Clinical Oncology
14. International survey on the use of preoperative chemotherapy in the setting of multimodality management of intrahepatic cholangiocarcinoma
    Elena Panettieri, Agostino Maria De Rose, Eduardo A. Vega, William Kawahara, Alessandro Coppola, Francesco Ardito, Felice Giuliante · 2025 · HPB
15. Human chorion and placental mesenchymal stem cells conditioned media suppress cell migration and invasion by inhibiting the PI3K/AKT pathway in cholangiocarcinoma
    Tanachapa Jantalika, Sirikul Manochantr, Pakpoom Kheolamai, Duangrat Tantikanlayaporn, Somchai Pinlaor, Weerachai Saijuntha, Luminita Paraoan, Chairat Tantrawatpan · 2025 · Scientific Reports
16. DNMT3B Knockdown Enhances PARP Inhibitor Sensitivity in Biliary Tract Cancer Cells via Opioid Growth Factor Receptor-Mediated Homologous Recombination Impairment
    Soichiro Oda, Kazumichi Kawakubo, Masaki Kuwatani, Shugo Tanaka, Katsuma Nakajima, Shoya Shiratori, Hiroki Yonemura, Shunichiro Nozawa, Koji Hirata, Ryo Sugiura et al. · 2025 · Cancers
17. Disitamab vedotin in combination with lenvatinib for patients with HER2-positive unresectable locally advanced or metastatic biliary tract cancer: study protocol of a phase II clinical trial
    Yongqiang Yang, Jinfeng Zhang, Zilong Wu, Dongen Liu, Jing Tang, Jun Xue, G. R. WU · 2026 · BMJ Open
18. Diverse Biological Functions of IGF2BPs in Hepatobiliary Cancers and Their Clinical Relevance
    Zhijie Yin, Qingfu Lang, Peng Xiao, Chen Jia, Jiayu Sun, Tiemin Pei · 2026 · Frontiers in Bioscience-Landmark
19. Metformin use and the risk of liver cancer in a Swedish population-based cohort study
    Yongying Huang, Giola B. Santoni, Ernesto Sparrelid, Shao‐Hua Xie · 2026 · JNCI Cancer Spectrum
20. Transiently Elevated TC and sdLDL-C Levels and Falsely Low LDL-C Levels in Patients with Extrahepatic Cholangiocarcinoma
    Yi Chen Guo, Yonggen Zhang, Hongchun Li, Yinhai Xu · 2021 · OncoTargets and Therapy
21. Intrahepatic cholangiocarcinoma initially diagnosed as adenocarcinoma of unknown primary with hepatoduodenal ligament lymph node metastases: A case report
    Sangik Noh, Ahrong Ham, Je Ryung Gil, Miji Lee, Taekyu Lim · 2023 · Oncology Letters
22. ASO Author Reflections: Early-Onset Intrahepatic Cholangiocarcinoma—Poor Oncological Outcomes and Distinct Molecular Features
    Diamantis I. Tsilimigras, Timothy Michael Pawlik · 2024 · Annals of Surgical Oncology
23. Beyond body mass index : Body composition profiling for perioperative risk stratification in intrahepatic cholangiocarcinoma patients
    Johannes Kolck, Clarissa Hosse, Nick Lasse Beetz, Timo Alexander Auer, Adrian A. Marth, Laura Segger, Felix Krenzien, Georg Lurje, Uwe Pelzer, Dominik Geisel et al. · 2024 · Cancer Reports
24. Standardized reporting of intrahepatic cholangiocarcinoma
    Andrea Siobhan Kierans, Guilherme Moura Cunha, Michael J. King, Robert M. Marks, Frank H. Miller, Jeong Min Lee, Aliya Qayyum · 2024 · Abdominal Radiology
25. Zinc Finger Protein 263 Augments Autophagy and Promotes Intrahepatic Cholangiocarcinoma Proliferation
    Zaihua Yan, Yadan Du, Ya‐Wen Chen, Jian Yang, Haoyang Zhang, Mingxu Da · 2024 · Molecular Carcinogenesis
26. Efficacy and safety of PD-1 inhibitors for advanced intrahepatic cholangiocarcinoma with or without MAFLD
    Teng Long, Zhenyun Yang, Weijie Wu, Minshan Chen, Dandan Hu · 2025 · iLiver
27. Recent advances in the management of intrahepatic cholangiocarcinoma: the role of actionable mutations and targeted therapies
    Wilson Mawutor Alobuia, Timothy Michael Pawlik · 2025 · Expert Review of Anticancer Therapy
28. Bmi1 Promotes Cholangiocarcinoma Progression And Correlates With Antitumor Immunity In An Exosome-Dependent Manner
    Zengli Liu, Chunxiao Hu, Lijie Zheng, Jialiang Liu, Kangshuai Li, Xingyong Li, Yue Wang, Wentao Mu, Tianli Chen, Anda Shi et al. · 2022 · Research Square
29. Futibatinib: Paving the Way to Personalized Medicine in Intrahepatic Cholangiocarcinoma
    Rita Khoury, Claude Chahine, Rebecca Ibrahim, Nadine Khalife, Mohammad Saleh, Khalil Saleh · 2023 · Future Oncology
30. Natural history of a parasite–induced biliary cancer
    Thomas Crellen, Francesca Vita, Chiara Braconi, Paiboon Sithithaworn, T. Déirdre Hollingsworth · 2024 · medRxiv
31. INTS8 Predicts a Therapeutic Target for Intrahepatic Cholangiocarcinoma via Integration of Bioinformation Analysis and Experimental Validation
    Qi Zhou, Ji Li, Xueying Shi, Dawei Deng, Fangyue Guo, Zhengpeng Wang, Wenhui Liu, Jinnan Zhang, Shilin Xia, Dong Shang · 2021 · Research Square
32. Chemotherapy for Unresectable Cholangiocarcinoma
    Takashi Sasaki · 2021 · Springer eBooks
33. Risk Factors for Pancreatic Cancer and Cholangiocarcinoma
    Tsuyoshi Hamada, Yousuke Nakai · 2021 · Springer eBooks
34. Exosome-Mediated Bmi1 Promotes Cholangiocarcinoma Growth and Metastasis Through the Differential Regulation of miR-320b and miR-27b-3p
    Zengli Liu, Chunxiao Hu, Yue Wang, Rongqi Sun, Yunfei Xu, Yanli Zhang, Xin Min Zheng, Xin Zhang, Zongli Zhang · 2021 · SSRN Electronic Journal
35. 频道制全成本核算：预算是核心，节目质量是根本
    刘晓岗 · 2010 · 视听界
36. Faculty Opinions recommendation of Mesenchymal stem cells promote chemoresistance by activating autophagy in intrahepatic cholangiocarcinoma.
    Fabio Marra, Alessandra Gentilini · 2021 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
37. Operative Therapie des intra- und extrahepatischen cholangiozellulären Karzinoms
    Oliver Beetz, Kai Timrott · 2022 · Der Onkologe
38. BMI1 Promotes Cholangiocarcinoma Progression and Correlates with Antitumor Immunity in An Exosome-Dependent Manner
    Zengli Liu, Chunxiao Hu, Lijie Zheng, Jialiang Liu, Kangshuai Li, Xingyong Li, Yue Wang, Wentao Mu, Tianli Chen, Anda Shi et al. · 2022 · Research Square
39. DEK mediates AKT/mTOR signaling pathway promotes the proliferation, migration and EMT process of cholangiocarcinoma
    Xuebing Zhou, Chunyu Yang, Dan Chen, Tong Wang, Xiangshan Ren · 2022 · Research Square
40. Comparison of short-term efficiency of endoscopic biliary drainage and percutaneous transhepatic biliary drainage in the treatment of obstructive jaundice caused by hilar cholangiocarcinoma: a propensity score matching analysis
    Dalong Zhu, Musitafa Zayier, Alimu Tulahong, Abuduhaiwaier Abuduhelili, Fashun Lu, Bo Ran, Tiemin Jiang, Yingmei Shao, Tuerganaili Aji · 2022 · Research Square
41. Pancreas and Biliary Diseases
    Seon Mee Park · 2022 · Springer eBooks
42. In vivo Right Hepatectomy and its Autotransplantation with Inferior Vena Cava Replacement for Conventionally Unresectable Intrahepatic Cholangiocarcinoma: A Case Report
    Sang Hoon Kim · 2022 · Journal of Surgery
43. Prognostic analysis of m6A-related lncRNAs as potential biomarkers in intrahepatic cholangiocarcinom
    Guodong Shi, Jijun Wang, Weiqi Wang, Min Chen, Xiaoxuan Liu, Yufan Zheng, Yi Fu, Minghua Wang, Xiaojie Zhang · 2022 · Frontiers in Genetics
44. Validation of the Thai Version of the Memorial Symptom Assessment Scaled - Short Form Among Cholangiocarcinoma Patients
    Ueamporn Summart, Monthida Sangruangake, Saranya T. Teinprasert, Napachun Chaplik, Ponpimon Srisuwan · 2022 · Asian Pacific Journal of Cancer Prevention
45. Targeting Fibroblast Growth Factor Receptor Alterations in Cholangiocarcinoma and Other Solid Tumours: A New Frontier in Personalised Medicine
    Filippo de Braud, Juan W. Valle, Ángela Lamarca, David Malka, Antoine Hollebecque · 2022 · EMJ Oncology
46. Age-wise cancer incidence in western Uttar Pradesh in India: An observational study
    Mohammad Akram, Mahbooba Khazir, Mohsin S. Khan, Ruquiya Afrose · 2022 · Journal of Cancer Research and Therapeutics
47. Epidemiology and Etiology
    Hoon Jai Chun, Seun Ja Park, Yun Jeong Lim, Si Young Song · 2023 · Springer eBooks
48. Insights on liver transplantation and multimodal treatment for intrahepatic cholangiocarcinoma
    Shankar I. Logarajah, John Nida, Ève Simoneau, Lavanya Yohanathan · 2023 · Hepatoma Research
49. Development and validation of a web-based nomogram for predicting cancer-specific survival in patients with intrahepatic cholangiocarcinoma: A SEER database analysis
    Yao-Ge Liu, Shitao Jiang, Junwei Zhang, Lei Zhang, Haitao Zhao, Xinting Sang, Xin Lü, Yiyao Xu · 2023 · Research Square
50. Temporal trends of liver cancer burden, comparative analysis of risk factors and trend forecasts to 2025 in China, the United States, Republic of Korea and Mongolia——systematic analysis based on multiple data sources from GBD 2019, GLOBOCAN, and CI5
    Xing Yao, Xinchun Ling, ziyi zhu, xiaolu cao, Shaoliang Tang · 2024 · Research Square
51. Cholangiocarcinoma and Occupational Exposure to Asbestos: Insights From the Italian Pooled Cohort Study
    Stefania Curti, Mena Gallo, Daniela Ferrante, Francesca Bella, Lorenza Boschetti, Veronica Casotto, Marcello Ceppi, Daniela Cervino, Lucia Fazzo, Ugo Fedeli et al. · 2024 · La Medicina del Lavoro
52. Cholangiocarcinoma, sequential chemotherapy, and prognostic tests
    Howard W. Bruckner, Robert De Jager, Elisheva Knopf, Fred Bassali, Abe Book, Daniel Gurell, Van Thi Ha Nghiem, M. Schwartz, Azriel Hirschfeld · 2024 · Frontiers in Oncology
53. A Case Report and Literature Review of Intrahepatic Cholangiocarcinoma with Bone and Tonsillar Metastases
    甜 郭 · 2024 · Advances in Clinical Medicine
54. Disparate Tumor Characteristics and Survival Outcomes Between Squamous Cell and Adenocarcinoma Subtypes in Cholangiocarcinoma
    Jad Mitri, Sara Ajjour, Elena Panettieri, Hind El Naamani, Syed Kashif. Mahmood, Eduardo A. Vega · 2024 · Annals of Surgical Oncology
55. The Dust Has Finally Settled, but Is the View Any Clearer?
    Eric David Miller, Jonathan B. Ashman, M. Hawkins, Krishan R. Jethwa, Hyun Jee Kim, Nina Niu Sanford, Andrzej Pawel Wojcieszynski, Michael David Chuong · 2024 · International Journal of Radiation Oncology*Biology*Physics
56. Malignant liver tumors
    Islam B. Mohamed, Ahmed El Sabagh, Fuad ZainAloor, Mohamed El Talkhan, Zahraa Al lami, Megha Bhongade, Shilpa Jain, Prasun K. Jalal · 2024 · Elsevier eBooks
57. Validity of Diagnostic Codes and Laboratory Tests to Identify Cholangiocarcinoma and Its Subtypes
    Nicole D. Ferrante, Rebecca A. Hubbard, Kelley M. Weinfurtner, Anya I. Mezina, Craig W. Newcomb, Emma Elizabeth Furth, Debika Bhattacharya, Basile M. Njei, Tamar Hamosh Taddei, Amit Singal et al. · 2025 · Pharmacoepidemiology and Drug Safety
58. The impact of serum ferritin on overall survival following resection in patients with intrahepatic cholangiocarcinoma
    Laura Schwenk, Carlos Wolf, Felix Dondorf, Oliver Rohland, Aladdin Ali Deeb, Utz Settmacher, Falk Rauchfuß · 2025 · Langenbeck s Archives of Surgery
59. The diagnostic performance of an [18F]FDG PET/CT algorithm for preoperative evaluation of extrahepatic cholangiocarcinoma: a retrospective study
    Hui Yang, Yi Zhang, Zhiwei Guan, Can Li, Guanyun Wang, Hui Zhou, Ruimin Wang, Baixuan Xu · 2025 · Nuklearmedizin - NuclearMedicine
60. Immune Cells as Potential Targets for Intrahepatic Cholangio-carcinoma: Insights from Mendelian Randomization
    Xue Tao, Qiwen Xiang, Yinghao Lv, Yunshi Cai, Hong Mei Wu, Chang Xin Liu · 2025 · Research Square
61. Who benefits from adjuvant chemotherapy? Identification of early recurrence in intrahepatic cholangiocarcinoma patients after curative-intent resection using machine learning algorithms
    Qi Li, Hengchao Liu, Yubo Ma, Zhenqi Tang, Chen Chen, Dong Zhang, Zhimin Geng · 2025 · Frontiers in Oncology
62. Impact of Antiviral Treatment on Survival in HBV-Related Intrahepatic Cholangiocarcinoma Patients After Hepatectomy: A 14-Year Retrospective Follow-Up Study Based on the Propensity Score Matching Method
    Zhiqiang Chen, Hui Zhang, Long Zhang, Guoyong Han, Yao Zhang, Jindao Wu, Xiangcheng Li, Xiaoxin Mu, Xuehao Wang · 2025 · Therapeutics and Clinical Risk Management
63. USSGAN: Unsupervised Spectral and Spatial Attention-Based Generative Adversarial Network for Cholangiocarcinoma Detection
    Sravan Kumar Sikhakolli, Anuj Pradeep Deshpande, Pooja A. Nair, Suresh Aala, Sunil Chinnadurai, Vineela Chandra Dodda, Inbarasan Muniraj, Md. Abdul Latif Sarker, Hala Mostafa · 2025 · Chemical & Biomedical Imaging
64. Assessing trends in clonorchiasis incidence via prescription data analysis in South Korea
    Taeksang Lee, Jun Hyun Lee, Hanna Jin, Yun-Kyung Lee, Hyun Beom Song · 2025 · BMC Public Health
65. Global, regional, and national burden and trends of liver cancer due to hepatitis B in young adults from 1990 to 2021 and forecast to 2030: insights from the Global Burden of Disease Study 2021
    Jinbo Li, Yaling Li, Bihong Ke, Xiaosheng Zhang, Weigang Wang, Yandi Li, Jia Lian, Tian Yao, Keke Wang, Suping Wang et al. · 2025 · Internal and Emergency Medicine
66. Preoperative prediction of microvascular invasion in Intra-hepatic cholangiocarcinoma using serum tumor markers integrated with inflammatory and liver function indices
    Haizhou Qiu, Kunlin Chen, Yiwen Qiu, Yi Yang, Tao Wang, Wentao Wang, Jiang Li · 2025 · BMC Cancer
67. Transplant vs. Resection for Non-HCC Malignancies of the Liver
    Sibi Krishna Thiyagarajan, Arielle Jacover, Alfredo Verastegui, Katherine E. Poruk, John Andrew Stauffer · 2025 · Livers
68. Additional file 5 of MBD2 regulates the progression and chemoresistance of cholangiocarcinoma through interaction with WDR5
    Wang, Da, Chen, Junsheng, Wu, Guanhua, Fei Xiong, Wenzheng Liu, Wang, Qi, Kuai, Yiyang, Huang, Wenhua, Yongqiang Qi, Wang, Bing et al. · 2024 · Figshare
69. Additional file 1 of MBD2 regulates the progression and chemoresistance of cholangiocarcinoma through interaction with WDR5
    Wang, Da, Junsheng Chen, Wu, Guanhua, Fei Xiong, Wenzheng Liu, Wang, Qi, Kuai, Yiyang, Huang, Wenhua, Yongqiang Qi, Bing Wang et al. · 2024 · Figshare
70. Additional file 2 of Hypoxia-induced SKA3 promoted cholangiocarcinoma progression and chemoresistance by enhancing fatty acid synthesis via the regulation of PAR-dependent HIF-1a deubiquitylation
    Yananlan Chen, Xu, Xiao, Wang, Yirui, Zhang, Yaodong, Tao Zhou, Wangjie Jiang, Wang, Ziyi, Jiang Chang, Liu, Shuochen, Chen, Ruixiang et al. · 2024 · Figshare
71. Additional file 1 of Hypoxia-induced SKA3 promoted cholangiocarcinoma progression and chemoresistance by enhancing fatty acid synthesis via the regulation of PAR-dependent HIF-1a deubiquitylation
    Yananlan Chen, Xu, Xiao, Wang, Yirui, Zhang, Yaodong, Tao Zhou, Wangjie Jiang, Wang, Ziyi, Jiang Chang, Liu, Shuochen, Chen, Ruixiang et al. · 2023 · Figshare
72. Additional file 9 of MBD2 regulates the progression and chemoresistance of cholangiocarcinoma through interaction with WDR5
    Wang, Da, Chen, Junsheng, Wu, Guanhua, Fei Xiong, Wenzheng Liu, Wang, Qi, Kuai, Yiyang, Huang, Wenhua, Yongqiang Qi, Wang, Bing et al. · 2024 · Figshare
73. Additional file 3 of Hypoxia-induced SKA3 promoted cholangiocarcinoma progression and chemoresistance by enhancing fatty acid synthesis via the regulation of PAR-dependent HIF-1a deubiquitylation
    Yananlan Chen, Xu, Xiao, Wang, Yirui, Zhang, Yaodong, Tao Zhou, Wangjie Jiang, Wang, Ziyi, Jiang Chang, Liu, Shuochen, Ruixiang Chen et al. · 2024 · Figshare
74. Additional file 2 of Establishment and characterization of a new intrahepatic cholangiocarcinoma cell line derived from a Chinese patient
    Miao, Xin, Hu, Jinjing, Chai, Changpeng, Tang, Huan, Zhao, Zhenjie, Luo, Wei, Zhou, Wence, Xu, Hao · 2023 · Figshare
75. Additional file 7 of MBD2 regulates the progression and chemoresistance of cholangiocarcinoma through interaction with WDR5
    Wang, Da, Junsheng Chen, Wu, Guanhua, Fei Xiong, Wenzheng Liu, Wang, Qi, Kuai, Yiyang, Huang, Wenhua, Yongqiang Qi, Wang, Bing et al. · 2024 · Figshare
76. Additional file 6 of MBD2 regulates the progression and chemoresistance of cholangiocarcinoma through interaction with WDR5
    Wang, Da, Junsheng Chen, Wu, Guanhua, Fei Xiong, Wenzheng Liu, Wang, Qi, Kuai, Yiyang, Huang, Wenhua, Yongqiang Qi, Wang, Bing et al. · 2024 · Figshare
77. Additional file 8 of MBD2 regulates the progression and chemoresistance of cholangiocarcinoma through interaction with WDR5
    Wang, Da, Junsheng Chen, Wu, Guanhua, Fei Xiong, Wenzheng Liu, Wang, Qi, Kuai, Yiyang, Huang, Wenhua, Yongqiang Qi, Bing Wang et al. · 2024 · Figshare
78. Additional file 1 of Establishment and characterization of a new intrahepatic cholangiocarcinoma cell line derived from a Chinese patient
    Miao, Xin, Hu, Jinjing, Chai, Changpeng, Tang, Huan, Zhenjie Zhao, Luo, Wei, Zhou, Wence, Xu, Hao · 2023 · Figshare
79. Additional file 4 of MBD2 regulates the progression and chemoresistance of cholangiocarcinoma through interaction with WDR5
    Wang, Da, Junsheng Chen, Wu, Guanhua, Fei Xiong, Wenzheng Liu, Wang, Qi, Kuai, Yiyang, Huang, Wenhua, Yongqiang Qi, Bing Wang et al. · 2024 · Figshare
80. Additional file 2 of MBD2 regulates the progression and chemoresistance of cholangiocarcinoma through interaction with WDR5
    Wang, Da, Junsheng Chen, Wu, Guanhua, Fei Xiong, Wenzheng Liu, Wang, Qi, Kuai, Yiyang, Huang, Wenhua, Yongqiang Qi, Wang, Bing et al. · 2024 · Figshare
81. Additional file 3 of MBD2 regulates the progression and chemoresistance of cholangiocarcinoma through interaction with WDR5
    Wang, Da, Junsheng Chen, Wu, Guanhua, Fei Xiong, Wenzheng Liu, Wang, Qi, Kuai, Yiyang, Huang, Wenhua, Yongqiang Qi, Wang, Bing et al. · 2024 · Figshare
82. Real-world impact of the management of advanced perihilar and extrahepatic cholangiocarcinoma on prognosis
    Marie Decraecker, Valérie Aurillac, Jean‐Frédéric Blanc · 2025 · Hepatobiliary & pancreatic diseases international
83. Extrahepatic Cholangiocarcinoma
    Ranish K. Patel, F. Rocha · 2025 · Springer eBooks
84. Integrative single-cell and machine-learning analysis identifies ac4C-related S100A13 as a causal risk gene in cholangiocarcinoma
    Yi Zheng, Yan Lin, Zilin Wang, Fazong Wu · 2026 · BMC Cancer
85. Development and Validation of a Diagnostic Model for Biliary Tract Cancer Detection in Patients with Benign Biliary Disease: A Multicenter, Retrospective Case-Control Study
    Park Hc, K. Kim, Jonghyun Lee, Sung Yong Han, Chang Min Cho, Dong Wook Lee, Jun Heo, MK Jung, Hyeong Seok Nam, Jin Kyu Gahm et al. · 2026 · Research Square
86. Perihilar Extrahepatic Cholangiocarcinoma With Typical and Atypical Manifestations: Diagnostic Resolution During Autopsy
    Javier Alejandro Teco-Cortes, Tania Alejandra Galindo-García, Paola X Calderón-Navarro · 2026 · Cureus
87. From chemotherapy to molecular targeted therapy in advanced biliary tract cancer
    Abigail Miller, Kristin Hsu, Niall C. Tebbutt, Christos Stelios Karapetis, Timothy J. Price, Amitesh Chandra Roy · 2026 · Academia oncology.
88. Shift in Patterns of Care and Survival Outcomes of Hepatocellular Carcinoma in a Canadian Provincial Cancer Program
    Nikunj Patil, Amelia Baker, Christie Nashed, Gaby Rizk, Miray Eskandar, Hang Yu, David Peretz, Mariam Shenouda, Alessandra Cassano-Bailey · 2026 · Cureus
89. Time Toxicity in Patients With Advanced Biliary Tract Cancer Receiving Gemcitabine Plus Cisplatin With or Without Durvalumab
    Naohiro Okano, Angelo Pirozzi, Conor D. O’Donnell, Masato Hayashi, Pedro Luiz Serrano Usón, Celine Hoyek, Oluseyi Abidoye, Cody R. Eslinger, Binbin Zheng-Lin, Natalie M. Elliott et al. · 2026 · JCO oncology advances.
90. Menopausal hormone therapy and risk of liver cancer in a Swedish population-based cohort study
    Yongying Huang, Giola B. Santoni, Jessica L. Petrick, Victoria Wocalewski, Ernesto Sparrelid, Shao‐Hua Xie · 2026 · JNCI Journal of the National Cancer Institute
91. Liver
    Neda Zarrin‐Khameh, Maryam Mohammadkhani, M. Lisa Zhang · 2026 · Elsevier eBooks
92. Exploration of the evolving role of 18F-FDG PET/CT in evaluating extrahepatic cholangiocarcinoma lymph node metastasis
    Gao Zhihui, J N Xiao, Cheng Jin, Yiqiu Zhang, Tao Suo, Xiaojian Ni, Houbao Liu, Sheng Shen, Hongcheng Shi · 2026 · Research Square
93. Genomic landscape of cholangiocarcinoma in India: ethnic variants and implications for targeted therapy
    Moushumi Suryavanshi, Vikas Ostwal, Milind M. Javle, Manoj Kumar, Omshree Anil Shetty, Darshana Patil, Shivani Sharma, Sewanti Limaye, Amol Patel, Bhawna Sirohi et al. · 2026 · BMC Cancer
94. Ectopic β-hCG-Expressing Hepatic Neoplasm with Cutaneous Metastasis in a Young Postpartum Woman: A Case Report and Literature Review
    Yameng Zheng, Meiqin Yang, Wen Xu, Pintong Huang · 2026 · International Journal of Women s Health
95. Diagnostic value of dual-time-point 18F-fluorodeoxyglucose PET/computed tomography in differentiating benign and malignant extrahepatic bile duct occupying lesions
    Fubo Li · 2026 · Nuclear Medicine Communications
96. Case Report: Conversion therapy for initially unresectable intrahepatic cholangiocarcinoma
    Ying-Ao Liu, Qi Huang, X Z Gao, Wei Gao, Zeliang Hu, Fang Wang, Yuanxu Qu, Yamin Zheng · 2026 · Frontiers in Oncology
97. Survival benefit of surgical resection in elderly patients with extrahepatic cholangiocarcinoma: a propensity score-matched analysis
    Chaoran Chen, Xuming Zhang · 2026 · Langenbeck s Archives of Surgery
98. Salvage resection for FGFR2 fusion-positive intrahepatic cholangiocarcinoma after pemigatinib therapy: a case report and literature review
    Yuhang Kang, Fei Xie, Zhenru Wu, Yi Zhou, Tianfu Wen, Xiaoyun Zhang · 2026 · Frontiers in Oncology
99. Predicting Perineural Invasion and Prognosis in Intrahepatic Mass-Forming Cholangiocarcinoma Using DKI and Gadoxetic Acid-Enhanced MRI-Based Texture Analysis
    Qin-Yang Wu, Yan Shan, X J Wang, Yijun Pan, Chen Xu, Cai-Xia Fu, Robert Grimm, Pengju Xu · 2026 · Academic Radiology
100. An individualized nomogram for survival prediction in intrahepatic cholangiocarcinoma: a population-based analysis
     Hui Xie, Xiangyu Wang, Lingguang Shen, Fatao Hao, Yong Meng, Jianbin Du · 2026 · World Journal of Surgical Oncology